Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Myelodysplastic-Myeloproliferative Diseases × Carmustine × 1 year × Clear all

Sponsor

Conditions

Lymphoma, Non-Hodgkin 5 Lymphoma, Large B-Cell, Diffuse 5 Lymphoma, Mantle-Cell 4 Lymphoma 4 Hodgkin Disease 4 Recurrence 3 Lymphoma, Follicular 3 Uveal Melanoma 2 HIV Infections 2 Burkitt Lymphoma 2 Vasculitis, Central Nervous System 1 Stiff-Person Syndrome 1 Rasmussen subacute encephalitis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 1 Plasmablastic Lymphoma 1 Pediatric Brain Tumor 1 Pancreatic Neoplasms 1 Opsoclonus-Myoclonus Syndrome 1 Neuromyelitis Optica 1 Neoplasm Metastasis 1 Myasthenia Gravis 1 Melanoma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, T-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, B-Cell, Marginal Zone 1 Lambert-Eaton Myasthenic Syndrome 1

Interventions

Specimen Handling 7 Biopsy 6 Cyclophosphamide 5 ruxolitinib 4 Mycophenolic Acid 4 Busulfan 4 fludarabine phosphate 3 fludarabine 3 Whole-Body Irradiation 3 Tacrolimus 3 Melphalan 3 Injections 3 Decitabine 3 Cyclosporine 3 Azacitidine 3 venetoclax 2 decitabine and cedazuridine drug combination 2 Sirolimus 2 Methotrexate 2 Granulocyte Colony-Stimulating Factor 2 veliparib 1 tocilizumab 1 tagraxofusp 1 posaconazole 1 peginterferon alfa-2b 1 onvansertib 1 merphos 1 iadademstat 1 gilteritinib 1 fedratinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡